Clinical Trial Update: Nortriptyline for Idiopathic Gastroparesis [Phase 3]

View source ↗

Summary

Phase 3 study update on nortriptyline for idiopathic gastroparesis; results posted after completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Gastroparesis

Drugs mentioned

• Nortriptyline (nortriptyline)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Idiopathic Gastroparesis | Phase 3 | Status: COMPLETED | Results posted: 2015-04-16